Common use of Pharmaceutical Development Clause in Contracts

Pharmaceutical Development. All results for clevudine drug substance and drug product will be provided. • Excess CTM held by Triangle includes the following. • 13,580 5 mg clevudine capsules • 269 bottles of 50 mg clevudine capsules (30 per bottle) • 40 bottles of 50 mg clevudine capsules labeled for study CLV-202. • 293 bottles of placebo capsules (30 per bottle) The acquisition cost of this material is [BUCKWANG REDACTED] • A total of 41 kg of clevudine drug substance is available. The acquisition cost of this material is [BUCKWANG REDACTED]. • TSIBR intermediate to synthesize clevudine drug substance is available. The acquisition cost of this material needs to be determined. • A complete inventory of all analytical methods is being prepared.